{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T04:29:30Z","timestamp":1717302570645},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,6,24]],"date-time":"2003-06-24T00:00:00Z","timestamp":1056412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,6,24]],"date-time":"2003-06-24T00:00:00Z","timestamp":1056412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1007\/s00115-002-1433-x","type":"journal-article","created":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T21:58:25Z","timestamp":1079647105000},"page":"543-551","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Die Bedeutung von GABAA-Rezeptoren f\u00fcr Pathophysiologie und Therapie der Panikst\u00f6rung"],"prefix":"10.1007","volume":"74","author":[{"given":"R.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,6,24]]},"reference":[{"key":"1433_C1","unstructured":"American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington DC"},{"key":"1433_C2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.155.1.1","volume":"155","author":"American Psychiatric Association","year":"1998","unstructured":"American Psychiatric Association (1998) Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 155:1\u201334","journal-title":"Am J Psychiatry"},{"key":"1433_C3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1212\/WNL.52.6.1201","volume":"52","author":"CF Arndt","year":"1999","unstructured":"Arndt CF, Derambure P, Defoort-Dhellemmes S, Hache JC (1999) Outer retinal dysfunction in patients treated with vigabatrin. Neurology 52:1201\u20131205","journal-title":"Neurology"},{"key":"1433_C4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","volume":"45","author":"JC Ballenger","year":"1988","unstructured":"Ballenger JC, Burrows GD, DuPont RL,Jr et al. (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry 45:413\u2013422","journal-title":"Arch Gen Psychiatry"},{"key":"1433_C5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15622970209150621","volume":"3","author":"B Bandelow","year":"2002","unstructured":"Bandelow B, Zohar J, Hollander E, Kasper S, M\u00f6ller H-J (2002) Guidelines for the pharmacological treatment of anxiety and obsessive-compulsive disorders. World J Biol Psychiatry 3:171\u2013199","journal-title":"World J Biol Psychiatry"},{"key":"1433_C6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4088\/JCP.v58n0106e","volume":"58","author":"DH Barlow","year":"1997","unstructured":"Barlow DH (1997) Cognitive-behavioral therapy for panic disorder: current status. J Clin Psychiatry 58:32\u201336","journal-title":"J Clin Psychiatry"},{"key":"1433_C7","first-page":"168","volume":"3","author":"RJ Boerner","year":"1996","unstructured":"Boerner RJ, M\u00f6ller H-J (1996) Pharmakotherapie der Panikst\u00f6rung und\/oder Agoraphobie. Psychopharmakotherapie 3:168\u2013177","journal-title":"Psychopharmakotherapie"},{"key":"1433_C8","first-page":"1284","volume":"280","author":"RB Carter","year":"1997","unstructured":"Carter RB, Wood PL, Wieland S et al. (1997) Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3\u03b1-hydroxy-3-methyl-5\u03b1-pregnan-20-one), a selective high-affinity steroid modulator of the GABAA receptor. J Pharmacol Exp Ther 280:1284\u20131295","journal-title":"J Pharmacol Exp Ther"},{"key":"1433_C9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0165-6147(92)90094-M","volume":"13","author":"J-P Changeux","year":"1992","unstructured":"Changeux J-P, Devillers-Thiery A, Galzi J-L, Bertrand D (1992) New mutants to explore nicotinic receptor functions. Trends Pharmacol Sci 13:299\u2013301","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/jm0110789","volume":"45","author":"I Collins","year":"2002","unstructured":"Collins I, Moyes C, Davey WB et al. (2002) 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional selectivity for alpha 2\/alpha 3-subtypes of human GABA(A) receptor-ion channels. J Med Chem 45:1887\u20131900","journal-title":"J Med Chem"},{"key":"1433_C11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","volume":"59","author":"F Crestani","year":"2001","unstructured":"Crestani F, L\u00f6w K, Keist R, Mandelli M, M\u00f6hler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442\u2013445","journal-title":"Mol Pharmacol"},{"key":"1433_C12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/80553","volume":"3","author":"F Crestani","year":"2000","unstructured":"Crestani F, Martin JR, M\u00f6hler H, Rudolph U (2000) Resolving differences in GABAA receptor mutant mouse studies. Nat Neurosci 3:1059","journal-title":"Nat Neurosci"},{"key":"1433_C13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1192\/bjp.160.2.191","volume":"160","author":"Cross-national collaborative panic study. Second phase investigators","year":"1992","unstructured":"Cross-national collaborative panic study. Second phase investigators (1992) Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 160:191\u2013202","journal-title":"Br J Psychiatry"},{"key":"1433_C14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0893-133X(01)00242-1","volume":"25","author":"K Damianisch","year":"2001","unstructured":"Damianisch K, Rupprecht R, Lancel M (2001) The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25:576\u2013584","journal-title":"Neuropsychopharmacology"},{"key":"1433_C15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. Br Med J 314:180\u2013181","journal-title":"Br Med J"},{"key":"1433_C16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002130050241","volume":"130","author":"J Faulhaber","year":"1997","unstructured":"Faulhaber J, Steiger A, Lancel M (1997) The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmcology 130:285\u2013291","journal-title":"Psychopharmcology"},{"key":"1433_C17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(99)01318-8","volume":"20","author":"M Gasior","year":"1999","unstructured":"Gasior M, Carter RB, Witkin JM (1999) Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci 20:107\u2013112","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C18","first-page":"207","volume":"9","author":"KW Gee","year":"1995","unstructured":"Gee KW, McCauley LD, Lan NC (1995) A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9:207\u2013227","journal-title":"Crit Rev Neurobiol"},{"key":"1433_C19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","volume":"58","author":"AW Goddard","year":"2001","unstructured":"Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OAC, Charney DS, Krystal JH (2001) Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch Gen Psychiatry 58:556\u2013561","journal-title":"Arch Gen Psychiatry"},{"key":"1433_C20","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","volume":"96","author":"LD Griffin","year":"1999","unstructured":"Griffin LD, Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 96:13512\u201313517","journal-title":"Proc Natl Acad Sci USA"},{"key":"1433_C21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2999(92)90410-6","volume":"210","author":"TG Hales","year":"1992","unstructured":"Hales TG, Lambert JJ (1992) Modulation of GABAA and glycine receptors by clomethiazole. Eur J Pharmacol 210:239\u2013246","journal-title":"Eur J Pharmacol"},{"key":"1433_C22","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1074\/jbc.272.18.11723","volume":"272","author":"CAE Hauser","year":"1997","unstructured":"Hauser CAE, Wetzel CHR, Berning B, Gerner FM, Rupprecht R (1997) Flunitrazepam has an inverse agonistic effect on recombinant \u03b16\u03b22\u03b32 GABAA-receptors via a flunitrazepam-binding site. J Biol Chem 272:11723\u201311727","journal-title":"J Biol Chem"},{"key":"1433_C23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02741459","volume":"18","author":"S Hevers","year":"1998","unstructured":"Hevers S, L\u00fcddens H (1998) The diversity of GABAA receptors. Pharmacological and electrophysiologi\u00a0cal properties of GABAA channel subtypes. Mol Neurobiol 18:35\u201386","journal-title":"Mol Neurobiol"},{"key":"1433_C24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","volume":"16","author":"JJ Lambert","year":"1995","unstructured":"Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16:295\u2013303","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0893-133X(95)00157-9","volume":"15","author":"M Lancel","year":"1996","unstructured":"Lancel M, Cr\u00f6nlein TAM, Faulhaber J (1996) Role of GABAA receptors in sleep regulation. Differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 15:63\u201374","journal-title":"Neuropsychopharmacology"},{"key":"1433_C26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjp.0701769","volume":"123","author":"M Lancel","year":"1998","unstructured":"Lancel M, Faulhaber J, Deisz RA (1998) Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br J Pharmacol 123:1471\u20131477","journal-title":"Br J Pharmacol"},{"key":"1433_C27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/sleep\/22.1.33","volume":"22","author":"M Lancel","year":"1999","unstructured":"Lancel M, Ruigt GSF, Deisz RA (1999) Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep 22:33\u201342","journal-title":"Sleep"},{"key":"1433_C28","first-page":"10","volume":"36","author":"IE Leppik","year":"1995","unstructured":"Leppik IE (1995) Tiagabine: the safety landscape. Epilepsia 36:10\u201313","journal-title":"Epilepsia"},{"key":"1433_C29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K L\u00f6w","year":"2000","unstructured":"L\u00f6w K, Crestani F, Keist R et al. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131\u2013134","journal-title":"Science"},{"key":"1433_C30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","volume":"55","author":"AL Malizia","year":"1998","unstructured":"Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DN (1998) Decreased brain GABAA-benzodiazepine receptor binding in panic disorder. Arch Gen Psychiatry 55:715\u2013720","journal-title":"Arch Gen Psychiatry"},{"key":"1433_C31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.1718042","volume":"254","author":"AV Maricq","year":"1991","unstructured":"Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254:432\u2013437","journal-title":"Science"},{"key":"1433_C32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0197-4580(00)00232-3","volume":"22","author":"S Mathias","year":"2001","unstructured":"Mathias S, Wetter TC, Steiger A, Lancel M (2001) The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol Aging 22:247\u2013253","journal-title":"Neurobiol Aging"},{"key":"1433_C33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1037\/0022-006X.59.1.100","volume":"59","author":"LK Michelson","year":"1991","unstructured":"Michelson LK, Marchione K (1991) Behavioral, cognitive, and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. J Consult Clin Psychol 59:100\u2013114","journal-title":"J Consult Clin Psychol"},{"key":"1433_C34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/13543784.8.10.1663","volume":"8","author":"EP Monaghan","year":"1999","unstructured":"Monaghan EP, McAuley JW, Data JL (1999) Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy. Expert Opin Investig Drugs 8:1663\u20131671","journal-title":"Expert Opin Investig Drugs"},{"key":"1433_C35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","volume":"300","author":"H M\u00f6hler","year":"2002","unstructured":"M\u00f6hler H, Fritschy J-M, Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2\u20138","journal-title":"J Pharmacol Exp Ther"},{"key":"1433_C36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","volume":"47","author":"DJ Nutt","year":"1990","unstructured":"Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorders. Arch Gen Psychiatry 47:917\u2013925","journal-title":"Arch Gen Psychiatry"},{"key":"1433_C37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.179.5.390","volume":"179","author":"DJ Nutt","year":"2001","unstructured":"Nutt DJ, Malizia AL (2001) New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179:390\u2013396","journal-title":"Br J Psychiatry"},{"key":"1433_C38","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1096\/fasebj.4.5.2155149","volume":"4","author":"RW Olsen","year":"1990","unstructured":"Olsen RW, Tobin AJ (1990) Molecular biology of GABAA receptors. FASEB J 4:1469\u20131480","journal-title":"FASEB J"},{"key":"1433_C39","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","volume":"6","author":"SM Paul","year":"1992","unstructured":"Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311\u20132322.","journal-title":"FASEB J"},{"key":"1433_C40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0896-6273(90)90202-Q","volume":"4","author":"G Puia","year":"1990","unstructured":"Puia G, Santi MR, Vicini S et al. (1990) Neurosteroids act on recombinant human GABAA receptors. Neuron 4:759\u2013765","journal-title":"Neuron"},{"key":"1433_C41","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","volume":"155","author":"E Romeo","year":"1998","unstructured":"Romeo E, Str\u00f6hle A, Spalletta G et al. (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910\u2013913","journal-title":"Am J Psychiatry"},{"key":"1433_C42","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archpsyc.1990.01810180034006","volume":"47","author":"PP Roy-Byrne","year":"1990","unstructured":"Roy-Byrne PP, Cowley DS, Greenblatt DJ (1990) Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 47:534\u2013538","journal-title":"Arch Gen Psychiatry"},{"key":"1433_C43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","volume":"401","author":"U Rudolph","year":"1999","unstructured":"Rudolph U, Crestani F, Benke D et al. (1999) Benzodiazepine actions mediated by specific \u03b3-aminobutyric acidA receptor subtypes. Nature 401:796\u2013797","journal-title":"Nature"},{"key":"1433_C44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)01646-1","volume":"22","author":"U Rudolph","year":"2001","unstructured":"Rudolph U, Crestani F, M\u00f6hler H (2001) GABAA receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 22:188\u2013194","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","volume":"22","author":"R Rupprecht","year":"1999","unstructured":"Rupprecht R, Holsboer F (1999) Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410\u2013416","journal-title":"Trends Neurosci"},{"key":"1433_C46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0074-7742(01)46072-7","volume":"46","author":"R Rupprecht","year":"2001","unstructured":"Rupprecht R, Holsboer F (2001) Neuroactive steroids in neuropsychopharmacology. Int Rev Neurobiol 46:461\u2013477","journal-title":"Int Rev Neurobiol"},{"key":"1433_C47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0896-6273(93)90156-L","volume":"11","author":"R Rupprecht","year":"1993","unstructured":"Rupprecht R, Reul JMHM, Trapp T et al. (1993) Progesterone receptor-mediated effects of neuroactive steroids. Neuron 11:523\u2013530","journal-title":"Neuron"},{"key":"1433_C48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026988110101500312","volume":"15","author":"JJ Sandford","year":"2001","unstructured":"Sandford JJ, Forshall S, Bell C et al. (2001) Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder. J Psychopharmacol 15:205\u2013208","journal-title":"J Psychopharmacol"},{"key":"1433_C49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0091-3057(92)90188-L","volume":"43","author":"\u00dc Sayin","year":"1992","unstructured":"Sayin \u00dc, Purali N, \u00d6zkan T, Altug T, B\u00fcy\u00fckdevrim S (1992) Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 43:529\u2013535","journal-title":"Pharmacol Biochem Behav"},{"key":"1433_C50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199903000-00002","volume":"10","author":"U Schmitt","year":"1999","unstructured":"Schmitt U, Hiemke C (1999) Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze. Behav Pharmacol 10:131\u2013137","journal-title":"Behav Pharmacol"},{"key":"1433_C51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0091-3057(99)00208-7","volume":"65","author":"U Schmitt","year":"2000","unstructured":"Schmitt U, L\u00fcddens H, Hiemke C (2000) Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition. Pharmacol Biochem Behav 65:351\u2013356","journal-title":"Pharmacol Biochem Behav"},{"key":"1433_C52","first-page":"38","volume":"58","author":"MK Shear","year":"1997","unstructured":"Shear MK, Weiner K (1997) Psychotherapy for panic disorder. J Clin Psychiatry 58:38\u201343","journal-title":"J Clin Psychiatry"},{"key":"1433_C53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0165-6147(92)90142-S","volume":"13","author":"W Sieghart","year":"1992","unstructured":"Sieghart W (1992) GABAA receptors: ligand-gated Cl-ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 13:446\u2013450","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0165-6147(00)01564-9","volume":"21","author":"W Sieghart","year":"2000","unstructured":"Sieghart W (2000) Unraveling the function of GABAA receptor subtypes. Trends Pharmacol Sci 21:411\u2013413","journal-title":"Trends Pharmacol Sci"},{"key":"1433_C55","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1176\/ajp.155.5.610","volume":"155","author":"A Str\u00f6hle","year":"1998","unstructured":"Str\u00f6hle A, Kellner M, Yassouridis A, Holsboer F, Wiedemann K (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610\u2013612","journal-title":"Am J Psychiatry"},{"key":"1433_C56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","volume":"159","author":"A Str\u00f6hle","year":"2002","unstructured":"Str\u00f6hle A, Romeo E, di Michele F, Pasini A, Yassouridis A, Holsboer F, Rupprecht R (2002) GABAA receptor modulatory neuroactive steroid composition in panic disoder and during paroxetine treatment. Am J Psychiatry 159:145\u2013147","journal-title":"Am J Psychiatry"},{"key":"1433_C57","doi-asserted-by":"crossref","unstructured":"Str\u00f6hle A, Romeo E, di Michele F et al. (2002) Induced panic attacks shift GABAA receptor modulatory steroid composition in patients with panic disorder: preliminary results. Archives of General Psychiatry (im Druck)","DOI":"10.1001\/archpsyc.60.2.161"},{"key":"1433_C58","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239\u20133244","journal-title":"Proc Natl Acad Sci USA"},{"key":"1433_C59","first-page":"337","volume":"295","author":"KE Vanover","year":"2000","unstructured":"Vanover KE, Rosenzweig-Lipson S, Hawkinson JE et al. (2000) Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2\u20136749 (GMA-839; WAY-141839; 3\u03b1, 21-Dihydroxy-3\u03b2-trifluoromethyl-19-nor-5\u03b2-pregnan-20-one), a selective modulator of \u03b3-aminobutyric acidA receptors. J Pharmacol Exp Ther 295:337\u2013345","journal-title":"J Pharmacol Exp Ther"},{"key":"1433_C60","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","volume":"267","author":"HA Wieland","year":"1992","unstructured":"Wieland HA, L\u00fcddens H, Seeburg PH (1992) A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267:1426\u20131429","journal-title":"J Biol Chem"},{"key":"1433_C61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s002130050424","volume":"134","author":"S Wieland","year":"1997","unstructured":"Wieland S, Belluzzi J, Hawkinson JE et al. (1997) Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3\u20130593. Psychopharmcol 134:46\u201354","journal-title":"Psychopharmcol"},{"key":"1433_C62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0959-4388(92)90113-Y","volume":"2","author":"W Wisden","year":"1992","unstructured":"Wisden W, Seeburg PH (1992) GABAA receptor channels: from subunits to functional entities. Curr Opin Neurobiol 2:263\u2013269","journal-title":"Curr Opin Neurobiol"},{"key":"1433_C63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00004714-200110000-00017","volume":"21","author":"P Zwanzger","year":"2001","unstructured":"Zwanzger P, Baghai T, Boerner RJ, M\u00f6ller H-J, Rupprecht R (2001) Anxiolytic effects of vigabatrin in panic disorder. J Clin Psychopharmacol 21:539\u2013540","journal-title":"J Clin Psychopharmacol"},{"key":"1433_C64","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4088\/JCP.v62n0813d","volume":"62","author":"P Zwanzger","year":"2001","unstructured":"Zwanzger P, Baghai TC, Sch\u00fcle C, Minov C, Padberg F, M\u00f6ller H-J, Rupprecht R (2001) Tiagabine improves panic and agoraphobia in panic disorder patients. J Clin Psychiatry 62:656\u2013657","journal-title":"J Clin Psychiatry"},{"key":"1433_C65","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","volume":"25","author":"P Zwanzger","year":"2001","unstructured":"Zwanzger P, Baghai TC, Sch\u00fcle C et al. (2001) Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology 25:699\u2013703","journal-title":"Neuropsychopharmacology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-002-1433-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1433-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-002-1433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:38:27Z","timestamp":1699349907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-002-1433-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,24]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["1433"],"URL":"https:\/\/doi.org\/10.1007\/s00115-002-1433-x","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,24]]},"assertion":[{"value":"24 June 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}